U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
186511186511SIMPADICO - Study of Immune Modulation Therapy in Peripheral Arterial Disease and Intermittent Claudication OutcomesTerminatedNo Results AvailablePeripheral Arterial Disease|Arterial Occlusive Diseases|Intermittent ClaudicationDevice: Celacadeâ„¢ systemhttps://ClinicalTrials.gov/show/NCT00111826
186512186512Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))CompletedHas ResultsMultiple MyelomaDrug: vorinostat|Drug: bortezomibhttps://ClinicalTrials.gov/show/NCT00111813
186513186513A New Oral Treatment For Type II Diabetes MellitusCompletedNo Results AvailableNon-Insulin-Dependent Diabetes MellitusDrug: GW0823093https://ClinicalTrials.gov/show/NCT00111800
186514186514Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast CancerCompletedNo Results AvailableBreast Cancer|Newly Diagnosed|ErbB2 Overexpressing|ErbB1 Expressing|InflammatoryDrug: Lapatinib|Drug: Paclitaxelhttps://ClinicalTrials.gov/show/NCT00111787
186515186515Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinomaCompletedNo Results AvailableColorectal Cancer|CarcinomaDrug: ABX-EGFhttps://ClinicalTrials.gov/show/NCT00111774
186516186516Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal CancerCompletedHas ResultsColorectal CancerDrug: Irinotecan|Biological: Panitumumab|Drug: 5-Fluorouracil|Drug: Leucovorinhttps://ClinicalTrials.gov/show/NCT00111761
186517186517Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory PatientsCompletedNo Results AvailableMultiple MyelomaDrug: Velcade, Thalidomide, Dexamethasonehttps://ClinicalTrials.gov/show/NCT00111748
186518186518Thyroxine Titration StudyActive, not recruitingNo Results AvailableHypothyroidismDrug: Thyroxinehttps://ClinicalTrials.gov/show/NCT00111735
186519186519Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)CompletedNo Results AvailableMigraineDrug: MK0462, rizatriptan benzoate / Duration of Treatment -1day|Drug: Comparator: placebo / Duration of Treatment - 1 dayhttps://ClinicalTrials.gov/show/NCT00111722
186520186520Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071)CompletedNo Results AvailableMigraineDrug: MK0462, rizatriptan benzoate / Duration of Treatment -1 day|Drug: Comparator: placebo / Duration of Treatment - 1 dayhttps://ClinicalTrials.gov/show/NCT00111709
186521186521Study of the Tumor Saturation and Biological Activity of MEDI-522 (Abergrin) in Patients With Advanced Malignant MelanomaCompletedNo Results AvailableMalignant MelanomaBiological: MEDI-522https://ClinicalTrials.gov/show/NCT00111696
186522186522MK0457 in Patients With Leukemia (0457-003)CompletedNo Results AvailableChronic Myelogenous Leukemia in Blast Crisis|Lymphocytic Leukemia, B Cell, Acute|Myelodysplastic Syndromes|Myelogenous Leukemia, ChronicDrug: MK0457https://ClinicalTrials.gov/show/NCT00111683
186523186523A Study of DPP-IV Inhibitor in Patients With Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: DPP-IV Inhibitor|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00111670
186524186524Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory GoutCompletedHas ResultsGoutBiological: Pegloticasehttps://ClinicalTrials.gov/show/NCT00111657
186525186525A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial PneumoniaCompletedNo Results AvailablePneumonia, BacterialDrug: Ceftriaxone|Drug: beta-lactam|Drug: beta-lactamhttps://ClinicalTrials.gov/show/NCT00111644
186526186526A Study of DPP-IV Inhibitor in Patients With Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: DPP-IV Inhibitor|Drug: Metformin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00111631
186527186527Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate CancerCompletedNo Results AvailableProstate CancerDrug: AS1404 (DMXAA)https://ClinicalTrials.gov/show/NCT00111618
186528186528Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected AdultsCompletedNo Results AvailableHIV InfectionsBiological: HIV-1 gag DNA|Biological: HIV-1 gag DNA plus IL-12 DNA adjuvant|Biological: CTL MEP/RC529-SE/GM-CSF (CTL MEP vaccine)|Biological: Sodium chloride injection (0.9%)https://ClinicalTrials.gov/show/NCT00111605
186529186529Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General PracticeCompletedNo Results AvailableBenign Prostatic Hyperplasia|Lower Urinary Tract SymptomsProcedure: current usual care|Procedure: treatment protocol with clear indications for therapyhttps://ClinicalTrials.gov/show/NCT00111592
186530186530Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With (TIV)CompletedNo Results AvailableInfluenzaBiological: CAIV-T|Other: TIVhttps://ClinicalTrials.gov/show/NCT00111579
186531186531BRIEF-PCI: Brief Infusion of Eptifibatide Following Percutaneous Coronary InterventionCompletedNo Results AvailableCoronary Artery Disease|Myocardial InfarctionDrug: eptifibatidehttps://ClinicalTrials.gov/show/NCT00111566
186532186532Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous LeishmaniasisCompletedNo Results AvailableLeishmaniasis, CutaneousBiological: Leish-111f + MPL-SE vaccinehttps://ClinicalTrials.gov/show/NCT00111553
186533186533Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: exenatidehttps://ClinicalTrials.gov/show/NCT00111540
186534186534APAF: Assessment of Cardiac Resynchronization Therapy in Patients With Permanent Atrial FibrillationCompletedNo Results AvailableCongestive Heart Failure|Atrial FibrillationOther: Optimized echo-guided CRT pacing|Other: normal RV pacinghttps://ClinicalTrials.gov/show/NCT00111527
186535186535Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal LeishmaniasisCompletedNo Results AvailableLeishmaniasis, MucocutaneousBiological: Leish-111f + MPL-SE vaccinehttps://ClinicalTrials.gov/show/NCT00111514
186536186536LGBT Internet Based Smoking Treatment - 1CompletedNo Results AvailableTobacco Use DisorderBehavioral: Tobacco Use Disorder|Behavioral: Standard Web-based interventionhttps://ClinicalTrials.gov/show/NCT00111501
186537186537Guidant Microwave Ablation System for the Treatment of Atrial FibrillationTerminatedNo Results AvailableAtrial FibrillationDevice: Flex 4 and Generatorhttps://ClinicalTrials.gov/show/NCT00111488
186538186538Evaluating the Safety and Efficacy of AMG531 in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura(ITP)CompletedNo Results AvailableIdiopathic Thrombocytopenic PurpuraDrug: AMG 531https://ClinicalTrials.gov/show/NCT00111475
186539186539Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle ChemotherapyCompletedNo Results AvailableAnemia|Non-Myeloid Malignancies|CancerDrug: Darbepoetin alfahttps://ClinicalTrials.gov/show/NCT00111462
186540186540Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With PsoriasisCompletedNo Results AvailablePsoriasisDrug: Etanercepthttps://ClinicalTrials.gov/show/NCT00111449

* Görseller ve İçerik tekif hakkına sahip olabilir